![[ Visit Client Website ]](images/banner.gif)
Learning Objectives
At the conclusion of this presentation attendees will be able to:
- Recognize some emerging tobacco products that may impact current tobacco use
- Compare NRT labeling in the US as compared to elsewhere in the world
- Understand different pharmacological approaches to cessation and explain the evolving US regulatory environment regarding nicotine and tobacco products, and the implications for treatment
General NCTOH attendees. No particular expertise is required, as this is geared towards those who are not expert in addiction.
Key Points:
This subplenary will focus on both the product as well as product labeling. Products will include medications, such as existing and pipeline nicotine tobacco products, as well as emerging products that may impact current tobacco use. These emerging products include smokeless and dissolvable tobacco products and electronic cigarettes. For those products that emerge as medications, there are questions regarding anticipated use and what information may be contained in the labeling.
Educational Experience:
No particular expertise is required, as this is geared towards those who are interested in learning more about the regulatory environment as it pertains to tobacco treatment.
Benefits:
This subplenary will provide the basis for discussion involving new cessation treatment as well as some products that may be used for cessation. From here, attendees will be better able to understand some of the emerging products that may be included throughout the conference.